ABSTRACT
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Conclusion
The complete absence of ghrelin acylation, which is associated with undetectable AG concentrations, does not prevent the marked increase in pituitary GH concentrations observed in pregnant mice, suggesting that AG is not the major mediator of GH secretion during pregnancy. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 INTRODUCTION Growth hormone (GH) release from the anterior pituitary gland classically involves stimulation by growth-hormone-releasing hormone (GHRH) and inhibition by somatostatin from the hypothalamus [1] .
Ghrelin is a 28 amino acid hormone mainly produced by the stomach in adult rodents and humans [2] . It circulates as acylated (AG) and unacylated ghrelin (UAG). Acylation is mediated by the enzyme ghrelin O-acyltransferase (GOAT) that attaches an octanoate group to the serine-3 residue of the peptide [3] . This is a key step that is required for the binding of AG to the GH secretagogue receptor (GHS-R1a) that mediates many of the actions ascribed to ghrelin [4] .
Exogenous administration of AG (but not UAG) causes a marked increase in circulating GH, raising the possibility that similar to somatostatin and GHRH, AG could play a physiological role in GH regulation [5, 6] . In addition, it has been recently demonstrated that in mice, vagotomy markedly lowered the GH response to exogenous AG administration suggesting the possibility of vagal stimulation in mediating AG's actions [7] .
Plasma GH concentrations are differently affected by pregnancy in humans and in mice.
In pregnant humans, maternal pituitary GH is gradually replaced by placental GH which has 91-99% identity with pituitary GH. Pituitary GH concentrations become almost undetectable during the 3 rd trimester of pregnancy [8] [9] [10] . In mice, the placenta does not produce a GH-like protein but instead produces mouse placental lactogens 1 and 2, which have a low identity with pituitary GH [11] . Plasma concentrations of pituitary GH increase markedly during pregnancy and are 9 times higher in pregnant mice near term compared to non-pregnant mice. However, as the GH binding protein concentrations also markedly increase, the concentration of free GH is little 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 5
The objective of this study was to investigate the role of AG and UAG in the surge in plasma GH concentrations in pregnant mice towards the end of pregnancy. Using a mouse model in which the GOAT gene has been deleted (GOAT KO), we demonstrate that the complete absence of ghrelin acylation, which is associated with undetectable AG concentrations, does not prevent the marked increase in pituitary GH concentrations observed in pregnant mice.
MATERIALS AND METHODS

Animals and diet
Eleven-12 week old female C57BL/6 wild-type (WT) and GOAT knock-out (KO) mice were used (Taconic, Hudson, NY, USA). GOAT KO mice are missing the gene that encodes for GOAT and are therefore unable to acylate ghrelin. They were generated on a C57BL/6 background as previously published [13] .
All mice were put on a 12-h light/12-h dark cycle (dark cycle starting at 5:30 PM) and were fed a 9% fat enriched diet (# 5058, PicoLab® Mouse Diet 20, St. Louis, MO, USA) until pregnancy was achieved, before being switched to a 5.4% fat standard chow diet (# 5P76, Remnants of food were removed by flushing the lumen of the stomach with cold DEPC treated PBS solution and rinsed further another 3 times. The hypothalamus and pituitary gland were then excised and, along with the stomach, were snap frozen in liquid nitrogen and stored at -80ºC.
RNA was isolated from the stomach, hypothalamus and pituitary gland using a mixed isolation method that allows for total protein and total RNA isolation. One microgram of RNA 
Statistical analysis
Except as otherwise noted, data are expressed as median (range) or median (25 th -75 th percentile). As many of the data were not normally distributed (Shapiro-Wilk test of normality) (Fig 2A) . As expected, GOAT mRNA was not detectable in KO animals. In WT animals, pregnancy did not significantly affect GOAT mRNA in the stomach or hypothalamus (Fig 2B) . In our hands, pituitary GOAT mRNA was below the limit of detection in WT animals.
DISCUSSION
We demonstrate that the physiological surge in pituitary GH during pregnancy in mice is not prevented by the absence of ghrelin acylation secondary to GOAT deletion. To our knowledge, this is the first study investigating the role of the GOAT-ghrelin axis in GH secretion during pregnancy in mice.
When discussing the role of AG, it is important to distinguish between its physiological role and the effect of the administration of exogenous AG on the GH axis. Administration of AG causes a marked increase in circulating GH in humans and mice [5, 15] . In contrast, the role of endogenous AG on GH secretion has been more difficult to demonstrate. Several models have been used. Deletion of the preproghrelin gene does not affect GH secretion or growth in mice fed 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 10 a standard diet [16, 17] . However, because ghrelin production is completely abolished, this model cannot distinguish between the effects of AG and UAG. If present, anomalies of the preproghrelin gene do not seem to have major effects on growth in humans.
Deletion of the GHS-R1a (through which AG exerts its effects) abolishes the GH response to exogenous AG without affecting the response to endogenous UAG. The modest but negative impact of GHS-R1a deletion on weight gain in these mice may be due to lower IGF-1 production (likely reflecting impaired GH secretion) and decreased fat and muscle mass [18] .
The more pronounced effects of GHS-R1a deletion compared to preproghrelin gene deletion may reflect the fact that GHS-R1 has a high basal, constitutive activity (50% of its maximal activity) which is unaffected by preproghrelin gene deletion. In humans, variations in the preproghrelin and GHS-R1a receptor genes are not common causes of short stature [19] . However, point mutations in the GHS-R1a have been associated with shorter height, suggesting that the ghrelin-GHS-R1a pathway plays some role in the regulation of longitudinal growth [20, 21] .
Finally, deletion of GOAT in animal models results in an absence of the acylation of ghrelin and undetectable circulating plasma AG concentrations. Production of UAG and the constitutive activation of the GHS-R1a remain present. Growth is not affected [22] and GH concentrations [23] in mice fed a normal diet remain normal. However, during prolonged starvation, Zhao et al (2010) observed that GOAT and AG were required for euglycemia maintenance, through their role in stimulating the secretion of GH, a counter regulatory hormone produced in response to hypoglycaemia. This concept has been recently challenged [24] . Taken together, these data suggest that there is redundancy in the mechanisms regulating GH secretion but that in specific circumstances, such as prolonged starvation, endogenous secretion of AG plays an important physiological role in boosting plasma GH and glucose concentrations. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11
The cause of the marked increase in circulating GH observed during pregnancy in rodents remains unclear. The placenta is an unlikely source in rodents, in contrast to humans [25, 26] . At the hypothalamo-pituitary level, a synergistic effect of GHRH and ghrelin could potentiate pituitary GH release [27] [28] [29] . Conversely, a decrease in somatostatin tone could also increase GH release by the pituitary. However, at least in rats, El Kasti, et al. (2008) [26] observed that hypothalamic GHRH gene expression was slightly decreased while somatostatin expression was markedly increased during pregnancy. Others reported that GHRH mRNA expression in the hypothalamus increased while GHRH-R mRNA expression decreased during the last week of rat pregnancy [30] . This was also associated with increased GHS-R1a expression in the pituitary.
Taken together, these data do not support the concept that major changes in expression in the hypothalamo-pituitary axis could explain the changes in circulating GH. Recently, it was shown that the vagus nerve played a crucial role in modulating GH secretion in the rat [7] . Whether changes in afferent vagal tone could explain the increase in GH secretion by the pituitary in rodent pregnancy is unknown. Finally, while a decrease in peripheral GH degradation could also be invoked, we are not aware of any published data supporting this hypothesis.
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Kruskal-Wallis: P < 0.0001 for GH. AG was statistically NS. N=6-14/gr Mann-Whitney: *: P < 0.0001 vs. corresponding group as indicated in the figure.
ND: not detected Kruskal-Wallis: P < 0.05 for pituitary and hypothalamus preproghrelin. All other GOAT and preproghrelin expression was statistically NS. N=6-11/gr (N=4 only for pituitary preproghrelin KO-P group). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 20 
